| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.57 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.3 | 0.05 |